Physician profile
Kisha D Thomas
NPI 1962728915
$4,833.52
in general payments reported to CMS, 2019-2025
37 companies · $1,282 in 2025
The $1,282 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $831 · 2021: $491 · 2022: $582 · 2023: $694 · 2024: $339 · 2025: $1,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,499 · Travel and Lodging: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.08 |
| Travel and Lodging | $816.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,001.74 | 2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $819.31 | 2019-2025 | Superion Indirect Decompression System, Bionic Navigator, Infinion 16 |
| Abbvie INC. | $797.48 | 2021-2025 | Ubrelvy, Qulipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $220.89 | 2019-2022 | |
| Amgen INC. | $216.01 | 2019-2022 | |
| Pfizer INC. | $211.81 | 2019-2024 | |
| Allergan, INC. | $189.90 | 2020 | |
| Collegium Pharmaceutical, INC. | $155.29 | 2019-2022 | |
| Horizon Therapeutics Plc | $149.46 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $123.28 | 2019-2021 | |
| Zyla Life Sciences, INC. | $121.26 | 2020 | |
| Abbott Laboratories | $105.93 | 2019-2022 | |
| Nevro Corp. | $87.09 | 2019-2024 | Senza |
| Biohaven Pharmaceutical Holding Company LTD. | $82.48 | 2022 | |
| Globus Medical, INC. | $49.24 | 2025 | Senza |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $34.74 | 2024 | Prolate, Nalocet |
| Stimwave Technologies Incorporated | $34.00 | 2019-2022 | |
| Valinor Pharma, LLC | $33.52 | 2023-2024 | Movantik |
| Almatica Pharma LLC | $32.70 | 2021-2022 | |
| Flowonix Medical Incorporated | $32.07 | 2019 | |
| Saluda Medical Americas, INC. | $29.99 | 2025 | Evoke |
| Avanos Medical | $28.40 | 2024 | Standard Rf Disposables |
| Astrazeneca Pharmaceuticals LP | $25.03 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $23.13 | 2021 | |
| Tersera Therapeutics LLC | $20.54 | 2019 | |
| Spr Therapeutics, INC | $19.62 | 2025 | Sprint Pns System |
| Amneal Pharmaceuticals LLC | $19.55 | 2023 | Lyvispah |
| Redhill Biopharma INC. | $19.42 | 2020 | |
| Protega Pharmaceutials INC | $19.34 | 2023 | Roxybond |
| Curonix LLC | $18.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kaleo, INC. | $18.17 | 2019 | |
| Scilex Pharmaceuticals INC. | $17.71 | 2024 | |
| Impel Pharmaceuticals INC. | $17.13 | 2022 | |
| Ibsa Pharma INC. | $16.12 | 2025 | Tirosint, Flector, Licart |
| Medtronic USA, INC. | $16.02 | 2019 | |
| Lilly USA, LLC | $13.42 | 2020 | |
| Biodelivery Sciences International, INC. | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kisha Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.